| | | | 
After 50 Years of Chemo, One Biotech Looks to Lead the Next Cancer Breakthrough For decades, chemotherapy has come at a heavy cost. Now, one biotech's breakthrough could finally change that. With early data showing precision without poison, this may be one of the most meaningful stories in biotech. See the full story and the company driving it forward
We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company's SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. |
|
